Tabor E - Search Results

1

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Biswas R, Tabor E, Hsia CC, Wright DJ, Laycock ME, Fiebig EW, Peddada L, Smith R, Schreiber GB, Epstein JS, Nemo GJ, Busch MP. Biswas R, et al. Among authors: tabor e. Transfusion. 2003 Jun;43(6):788-98. doi: 10.1046/j.1537-2995.2003.00424.x. Transfusion. 2003. PMID: 12757531

2

NAT screening of blood and plasma donations: evolution of technology and regulatory policy.

Tabor E, Epstein JS. Tabor E, et al. Transfusion. 2002 Sep;42(9):1230-7. doi: 10.1046/j.1537-2995.2002.00183.x. Transfusion. 2002. PMID: 12430684 Review. No abstract available.

3

Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.

Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E. Hsia CC, et al. Among authors: tabor e. J Med Virol. 2003 May;70(1):20-6. doi: 10.1002/jmv.10353. J Med Virol. 2003. PMID: 12629639

4

Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses.

Tabor E, Yu MY, Hewlett I, Epstein JS. Tabor E, et al. Transfusion. 2000 Oct;40(10):1273-5. doi: 10.1046/j.1537-2995.2000.40101273.x. Transfusion. 2000. PMID: 11061868 No abstract available.

5

Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma.

Hsia CC, Nakashima Y, Tabor E. Hsia CC, et al. Among authors: tabor e. Biochem Biophys Res Commun. 1997 Dec 29;241(3):726-9. doi: 10.1006/bbrc.1997.7882. Biochem Biophys Res Commun. 1997. PMID: 9434776

6

Studies to address reports of human T-lymphotropic virus type I tax sequences in US blood donors.

Cowan EP, Tabor E, Nemo G, Williams A, Lal RB, Busch MP. Cowan EP, et al. Among authors: tabor e. Transfusion. 1998 Aug;38(8):800-1. doi: 10.1046/j.1537-2995.1998.38898375523.x. Transfusion. 1998. PMID: 9709792 No abstract available.

7

Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study.

Cowan EP, Nemo GJ, Williams AE, Alexander RK, Vallejo A, Hewlett IK, Lal RB, Dezzutti CS, Gallahan D, George K, Pancake BA, Zucker-Franklin D, McCurdy PR, Tabor E. Cowan EP, et al. Among authors: tabor e. Transfusion. 1999 Aug;39(8):904-9. doi: 10.1046/j.1537-2995.1999.39080904.x. Transfusion. 1999. PMID: 10504129

8

Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma.

Hsia CC, Thorgeirsson SS, Tabor E. Hsia CC, et al. Among authors: tabor e. J Med Virol. 1994 Jul;43(3):216-21. doi: 10.1002/jmv.1890430304. J Med Virol. 1994. PMID: 7523580

9

Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas.

Yamaguchi R, Momosaki S, Gao G, Hsia CC, Kojiro M, Scudamore C, Tabor E. Yamaguchi R, et al. Among authors: tabor e. Int J Mol Med. 2004 Dec;14(6):1097-100. Int J Mol Med. 2004. PMID: 15547681

10

Summary of a Food and Drug Administration workshop on nucleic acid testing to screen donations of blood and plasma for the hepatitis C virus.

Tabor E, Hewlett I, Yu MY, Farshid M, Epstein JS. Tabor E, et al. Transfusion. 1999 Aug;39(8):912-3. doi: 10.1046/j.1537-2995.1999.39080912.x. Transfusion. 1999. PMID: 10504131 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters